NEW YORK, Sept. 1, 2010 (GLOBE NEWSWIRE) -- Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage trials to treat and prevent Alzheimer’s disease (AD), has announced that Daniel G. Chain, Ph.D., the company’s chief executive officer and chairman of the board, will speak at the Rodman & Renshaw Annual Global Investment Conference in New York City on September 14, 2010.
